Accuray (NSDQ:ARAY) today announced it appointed Sandeep Chalke as senior VP and chief commercial officer, effective May 16.
Chalke will report to President and forthcoming CEO Suzanne Winter and will be responsible for the global commercial, product development, R&D and engineering functions of the Sunnyvale, California-based company.
“I am thrilled to join the Accuray team and have been impressed with the organization’s passion and commitment to creating a better future for cancer patients through technology innovation and advancing radiation therapy care. I look forward to leading the company’s efforts to drive patient access, gain market share and create long-term value for all stakeholders,” Chalke said in a news release.
Chalke has more than 25 years of medical device expertise in commercialization, business development and operations for a number of medtech segments, including interventional catheterization systems, diagnostic X-rays, C-arm linear accelerators, anesthesia and more. He has held numerous leadership roles at Medtronic, Acelity and GE Healthcare.
“Sandeep has a track record of delivering commercial growth, advancing global market expansion and building world-class customer support organizations. We welcome Sandeep to the Accuray team and look forward to his leadership in driving customer centricity throughout our organization and accelerating our commercialization strategy across global markets,” Winter said. “I believe Sandeep’s multi-sector medtech industry background will enable him to bring a unique perspective to our business that will help the Accuray team deliver on our corporate objectives.”